The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction

Sponsor
Vanderbilt University Medical Center (Other)
Overall Status
Terminated
CT.gov ID
NCT00616824
Collaborator
(none)
36
1
2
30
1.2

Study Details

Study Description

Brief Summary

This study intends to compare postoperative outcomes of a tissue expander placement following a mastectomy with two different operative techniques. This study will be randomized and double blinded comparing the traditional placement of the tissue expander under an inferolateral serratus muscle flap to a new technique which uses an acellular dermal matrix as an inferolateral sling, instead of the muscle flap.

The study we are proposing will evaluate the question of whether there is a difference between the traditional method of serratus flap and the new technique of using an acellular matrix with tissue expander placement. This will be a double blinded randomized study of thirty women in each group comparing outcomes which will include postoperative pain, complications (wound infection, hematoma, capsular contracture, etc), and patient satisfaction with the procedure.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Dermamatrix to cover lateral aspect of tissue expander
  • Procedure: Serratus anterior to cover lateral aspect of tissue expander
Phase 4

Study Design

Study Type:
Interventional
Actual Enrollment :
36 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction After Mastectomy: A Double-Blinded, Randomized Trial
Study Start Date :
Sep 1, 2007
Actual Primary Completion Date :
Mar 1, 2010
Actual Study Completion Date :
Mar 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Traditional Method

Arm which uses the Serratus Anterior muscle mobilization for lateral coverage of the tissue expander

Procedure: Serratus anterior to cover lateral aspect of tissue expander
Traditional use of serratus anterior for coverage of lateral aspect of tissue expander

Experimental: Dermamatrix Arm

Arm which uses Dermamatrix as the lateral expander coverage

Procedure: Dermamatrix to cover lateral aspect of tissue expander
Dermamatrix used to cover lateral aspect of breast tissue expander after mastectomy
Other Names:
  • Dermamatrix
  • Outcome Measures

    Primary Outcome Measures

    1. postoperative pain [perioperative up to 1 year]

    Secondary Outcome Measures

    1. aesthetic outcome [1 year]

    2. complications (infection, hematoma, capsular contracture) [1 year]

    3. Patient satisfaction [1 year]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients presenting to Dr. Wendel's clinic who are older than 17 years of age undergoing a mastectomy and wish to have breast reconstruction with a tissue expander or those who have previously undergone a mastectomy and are now seeking reconstruction will be solicited for the study.
    Exclusion Criteria:
    • Preoperative radiation therapy

    • Autoimmune disease

    • Fever

    • Uncontrolled diabetes mellitus

    • Inability to comprehend or cooperate with postoperative instructions

    • Local or systemic infection

    • Have any allergies to the excipient ingredients found in the matrix

    • Pregnancy

    • Low vascularity of the surrounding tissue

    • Mechanical trauma

    • Poor nutrition

    • Poor general medical condition

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Vanderbilt University Medical Center Nashville Tennessee United States 37232-2345

    Sponsors and Collaborators

    • Vanderbilt University Medical Center

    Investigators

    • Principal Investigator: Jason J. Wendel, M.D., Vanderbilt University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Vanderbilt University Medical Center
    ClinicalTrials.gov Identifier:
    NCT00616824
    Other Study ID Numbers:
    • 070415
    • 070415
    First Posted:
    Feb 15, 2008
    Last Update Posted:
    Apr 4, 2017
    Last Verified:
    Mar 1, 2017
    Keywords provided by Vanderbilt University Medical Center
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Apr 4, 2017